Medicines

  1. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
    €17,768.40
View as Grid List

1 Item

per page
Set Descending Direction